Xyrem approved for muscle problems in narcolepsy.
D002385:Cataplexy / Q000188:drug therapy*; D017277:Drug Approval; D006801:Humans; D009290:Narcolepsy / Q000188:drug therapy*; D009965:Orphan Drug Production; D012978:Sodium Oxybate / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D012978:Sodium Oxybate